Lv72
5000 积分 2023-04-01 加入
Navigating the landscape of EGFR TKI resistance in EGFR-mutant NSCLC — mechanisms and evolving treatment approaches
1天前
已完结
Case Report: Germline Mutation of T790M and Dual/Multiple EGFR Mutations in Patients with Lung Adenocarcinoma
8天前
已完结
Germline Mutations as Risk Factors for Lung Cancer: A Systematic Review and Meta-analysis
19天前
已完结
Mutational Characteristics and Clinical Outcomes for Lung Adenocarcinoma With EGFR Germline Mutations
19天前
已完结
Germline alterations in patients with lung cancer
1个月前
已完结
Ensartinib in Resected ALK-Positive Non–Small-Cell Lung Cancer
1个月前
已完结
Molecular characterisation of pancreatic ductal adenocarcinoma withNTRKfusions and review of the literature
2个月前
已完结
Supplementary Table S4 from Oncogenic Drivers and Therapeutic Vulnerabilities in KRAS Wild-Type Pancreatic Cancer
2个月前
已关闭
Real-World outcomes of Non-Small cell lung cancer patients harbouring KRAS G12C and KRAS G12D mutations
4个月前
已完结
Illustrating potential actionable drug targets of head and neck tumors based on comprehensive genomic landscape of 386 samples
4个月前
已完结
皖公网安备34019202002308
